These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1776859)

  • 1. C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen.
    Collyn-d'Hooghe M; Vandewalle B; Hornez L; Lantoine D; Revillion F; Lefebvre J; Kerckaert JP
    Anticancer Res; 1991; 11(6):2175-9. PubMed ID: 1776859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.
    Dubik D; Dembinski TC; Shiu RP
    Cancer Res; 1987 Dec; 47(24 Pt 1):6517-21. PubMed ID: 3677090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of c-myc overexpression on the growth characteristics of MCF-7 human breast cancer cells.
    Liu E; Santos G; Lee WM; Osborne CK; Benz CC
    Oncogene; 1989 Aug; 4(8):979-84. PubMed ID: 2668848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells.
    Tsai LC; Hung MW; Yuan CC; Chao PL; Jiang SY; Chang GG; Chang TC
    Anticancer Res; 1997; 17(6D):4557-62. PubMed ID: 9494568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
    Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
    Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human estrogen receptor gene, epidermal growth factor receptor gene, and oncogenes by estrogen and antiestrogen in MCF-7 breast cancer cells.
    Murayama Y; Kurata S; Mishim Y
    Cancer Detect Prev; 1988; 13(2):103-7. PubMed ID: 3242819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
    Nomura Y; Tashiro H; Takaeko F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc overexpression and endocrine resistance in breast cancer.
    McNeil CM; Sergio CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar EK; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Henshall SM; Musgrove EA; Sutherland RL
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):147-55. PubMed ID: 17052904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens.
    Hua W; Christianson T; Rougeot C; Rochefort H; Clinton GM
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):279-89. PubMed ID: 8541224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells.
    Lim YC; Li L; Desta Z; Zhao Q; Rae JM; Flockhart DA; Skaar TC
    J Pharmacol Exp Ther; 2006 Aug; 318(2):503-12. PubMed ID: 16690721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
    Kyprianou N; English HF; Davidson NE; Isaacs JT
    Cancer Res; 1991 Jan; 51(1):162-6. PubMed ID: 1899037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer.
    Roberts CG; Millar EK; O'Toole SA; McNeil CM; Lehrbach GM; Pinese M; Tobelmann P; McCloy RA; Musgrove EA; Sutherland RL; Butt AJ
    Oncogene; 2011 Jul; 30(28):3186-97. PubMed ID: 21383694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
    Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
    Osipo C; Gajdos C; Cheng D; Jordan VC
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.